Where Does Tenax Therapeutics Inc (TENX) Stock Fall in the Biotechnology Field After It Is Lower By -22.06% This Week?

Tenax Therapeutics Inc (TENX) is around the bottom of the Biotechnology industry according to InvestorsObserver. TENX received an overall rating of 31, which means that it scores higher than 31 percent of all stocks. Tenax Therapeutics Inc also achieved a score of 18 in the Biotechnology industry, putting it above 18 percent of Biotechnology stocks. Biotechnology is ranked 55 out of the 148 industries.

TENX has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on TENX!

See Full TENX Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Tenax Therapeutics Inc Stock Today?

Tenax Therapeutics Inc (TENX) stock is higher by 13.98% while the S&P 500 is lower by -0.76% as of 12:22 PM on Friday, Mar 10. TENX has risen $0.06 from the previous closing price of $0.46 on volume of 8,799,829 shares. Over the past year the S&P 500 has fallen -8.71% while TENX is lower by -95.56%. TENX lost -$0.48 per share the over the last 12 months. Click Here to get the full Stock Report for Tenax Therapeutics Inc stock.